Market closedNon-fractional

ProQR Therapeutics/PRQR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About ProQR Therapeutics

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Ticker

PRQR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Leiden, Netherlands

Employees

-

PRQR Metrics

BasicAdvanced
$147M
Market cap
-
P/E ratio
-$0.36
EPS
0.34
Beta
-
Dividend rate
$147M
0.34
3.113
3.076
38.405
55.214
-50.80%
-14.84%
-56.75%
12.705
4.2
4.2
-4.148
176.00%
-58.69%
126.63%
-27.31%

What the Analysts think about PRQR

Analyst Ratings

Majority rating from 7 analysts.
Buy

PRQR Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-165.21% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€4.6M
-25.81%
Net income
-€7.6M
40.74%
Profit margin
-165.21%
89.70%

PRQR Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 18.42%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-€0.10
-€0.07
-€0.07
-€0.09
-
Expected
-€0.11
-€0.09
€0.01
-€0.11
-€0.13
Surprise
-9.79%
-18.02%
-710.93%
-18.42%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ProQR Therapeutics stock?

ProQR Therapeutics (PRQR) has a market cap of $147M as of July 23, 2024.

What is the P/E ratio for ProQR Therapeutics stock?

The price to earnings (P/E) ratio for ProQR Therapeutics (PRQR) stock is 0 as of July 23, 2024.

Does ProQR Therapeutics stock pay dividends?

No, ProQR Therapeutics (PRQR) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next ProQR Therapeutics dividend payment date?

ProQR Therapeutics (PRQR) stock does not pay dividends to its shareholders.

What is the beta indicator for ProQR Therapeutics?

ProQR Therapeutics (PRQR) has a beta rating of 0.34. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell ProQR Therapeutics stock

Buy or sell ProQR Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing